352 related articles for article (PubMed ID: 32503473)
1. The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial.
Park KS; Ganesh AB; Berry NT; Mobley YP; Karper WB; Labban JD; Wahlheim CN; Williams TM; Wideman L; Etnier JL
BMC Neurol; 2020 Jun; 20(1):231. PubMed ID: 32503473
[TBL] [Abstract][Full Text] [Related]
2. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
3. Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning.
Stojanovic M; Jin Y; Fagan AM; Benzinger TL; Hassenstab J; Cruchaga C; Morris JC; Head D
Alzheimer Dis Assoc Disord; 2020; 34(3):212-219. PubMed ID: 32520736
[TBL] [Abstract][Full Text] [Related]
4. Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly.
Luck T; Then FS; Luppa M; Schroeter ML; Arélin K; Burkhardt R; Thiery J; Löffler M; Villringer A; Riedel-Heller SG
Neuropsychology; 2015 May; 29(3):382-387. PubMed ID: 25365563
[TBL] [Abstract][Full Text] [Related]
5. The Physical Activity and Alzheimer's Disease (PAAD) Study: Cognitive outcomes.
Etnier JL; Karper WB; Labban JD; Piepmeier AT; Shih CH; Dudley WN; Henrich VC; Wideman L
Ann Behav Med; 2018 Feb; 52(2):175-185. PubMed ID: 29538632
[TBL] [Abstract][Full Text] [Related]
6. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
7. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.
Johnson SC; Schmitz TW; Trivedi MA; Ries ML; Torgerson BM; Carlsson CM; Asthana S; Hermann BP; Sager MA
J Neurosci; 2006 May; 26(22):6069-76. PubMed ID: 16738250
[TBL] [Abstract][Full Text] [Related]
8. Physical Activity, APOE Genotype, and Cognitive Decline: Exploring Gene-Environment Interactions in the UK Biobank.
Folley S; Zhou A; Llewellyn DJ; Hyppönen E
J Alzheimers Dis; 2019; 71(3):741-750. PubMed ID: 31450492
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.
Durazzo TC; Mattsson N; Weiner MW;
Nicotine Tob Res; 2016 Feb; 18(2):204-11. PubMed ID: 25847292
[TBL] [Abstract][Full Text] [Related]
10. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
11. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
12. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
[TBL] [Abstract][Full Text] [Related]
13. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
[TBL] [Abstract][Full Text] [Related]
14. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
[TBL] [Abstract][Full Text] [Related]
15. Acute Exercise Effect on Neurocognitive Function Among Cognitively Normal Late-Middle-Aged Adults With/Without Genetic Risk of AD: The Moderating Role of Exercise Volume and APOE Genotype.
Chang YK; Etnier JL; Li RH; Ren FF; Ai JY; Chu CH
J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37526237
[TBL] [Abstract][Full Text] [Related]
16. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
[TBL] [Abstract][Full Text] [Related]
18. Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife.
Rajah MN; Wallace LMK; Ankudowich E; Yu EH; Swierkot A; Patel R; Chakravarty MM; Naumova D; Pruessner J; Joober R; Gauthier S; Pasvanis S
Neuroimage Clin; 2017; 14():760-774. PubMed ID: 28413778
[TBL] [Abstract][Full Text] [Related]
19. Effects of low- and high-intensity physical exercise on physical and cognitive function in older persons with dementia: a randomized controlled trial.
Sanders LMJ; Hortobágyi T; Karssemeijer EGA; Van der Zee EA; Scherder EJA; van Heuvelen MJG
Alzheimers Res Ther; 2020 Mar; 12(1):28. PubMed ID: 32192537
[TBL] [Abstract][Full Text] [Related]
20. The multi-domain exercise intervention for memory and brain function in late middle-aged and older adults at risk for Alzheimer's disease: A protocol for Western-Eastern Brain Fitness Integration Training trial.
Chang YK; Erickson KI; Aghjayan SL; Chen FT; Li RH; Shih JR; Chang SH; Huang CM; Chu CH
Front Aging Neurosci; 2022; 14():929789. PubMed ID: 36062144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
